FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HIST1H1E | Histone cluster 1, H1e | Cancer-related genes
| | | | | Tissue enriched |
LIN28B | Lin-28 homolog B (C. elegans) | | | | | | Tissue enriched |
TEKT5 | Tektin 5 | | | | | | Tissue enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
POU2F3 | POU class 2 homeobox 3 | Transcription factors
| | | | | Tissue enriched |
STEAP2 | STEAP family member 2, metalloreductase | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ACTL6B | Actin-like 6B | | | | | | Tissue enriched |
ENO3 | Enolase 3 (beta, muscle) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
FAM131B | Family with sequence similarity 131, member B | | | | | | Tissue enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins
| | | | | Tissue enriched |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
LSMEM1 | Leucine-rich single-pass membrane protein 1 | Predicted membrane proteins
| | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
CAPS | Calcyphosine | | | | | | Tissue enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KIF4B | Kinesin family member 4B | Plasma proteins
| | | | | Tissue enriched |
NFE2 | Nuclear factor, erythroid 2 | Transcription factors
| | | | | Tissue enriched |
PLCD4 | Phospholipase C, delta 4 | Enzymes
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
GKAP1 | G kinase anchoring protein 1 | | | | | | Tissue enriched |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
MAPK12 | Mitogen-activated protein kinase 12 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
MYH6 | Myosin, heavy chain 6, cardiac muscle, alpha | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MYOD1 | Myogenic differentiation 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
ODF2 | Outer dense fiber of sperm tails 2 | | | | | | Tissue enriched |
RSPH4A | Radial spoke head 4 homolog A (Chlamydomonas) | Cytoskeleton related proteins Disease related genes
| | | | | Tissue enriched |
TBL2 | Transducin (beta)-like 2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
C19orf80 | Chromosome 19 open reading frame 80 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
CCDC110 | Coiled-coil domain containing 110 | | | | | | Tissue enriched |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | Enzymes Plasma proteins
| | | | | Tissue enriched |
DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 | Cytoskeleton related proteins Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DNAJC6 | DnaJ (Hsp40) homolog, subfamily C, member 6 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
FBXO43 | F-box protein 43 | | | | | | Tissue enriched |
GRK4 | G protein-coupled receptor kinase 4 | Enzymes
| | | | | Tissue enriched |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | | | | | | Tissue enriched |
NUP155 | Nucleoporin 155kDa | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PAX8 | Paired box 8 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
PGC | Progastricsin (pepsinogen C) | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |